---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-076433"
form_type: "8-K"
ticker: "CCEL"
cik: "0000862692"
company_name: "CRYO CELL INTERNATIONAL INC"
filed_at: "2025-05-22T23:59:59+00:00"
generated_at: "2026-05-20T19:49:58.711614+00:00"
event_type: "litigation"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Duke terminates patent license with Cryo-Cell effective May 17; Cryo-Cell previously sought arbitration

## Summary
- Duke University terminated Patent and Technology License Agreement effective May 17, 2025, claiming Cryo-Cell breached.
- Cryo-Cell had previously filed a demand for arbitration against Duke, alleging fraudulent inducement and breach.
- The license granted Cryo-Cell exclusive rights to commercialize certain products and processes for human disease treatment.
- Termination could impact Cryo-Cell's ability to commercialize the licensed technology; arbitration is ongoing.

## SEC filing metadata
- accession: 0000950170-25-076433
- form_type: 8-K
- ticker: CCEL
- cik: 0000862692
- company_name: CRYO CELL INTERNATIONAL INC
- filed_at: 2025-05-22T23:59:59+00:00
- event_type: litigation
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/862692/000095017025076433/0000950170-25-076433-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/862692/000095017025076433/ccel-20250517.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-076433
- JSON: https://secwatch.observer/filing/0000950170-25-076433.json
- Plain text: https://secwatch.observer/filing/0000950170-25-076433.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.